According to Oncodesign Precision Medicine's latest financial reports the company's current earnings are A$1.18 Million. In 2023 the company made an earning of -A$16.1 Million a decrease over its 2022 earnings that were of -A$2.59 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.